Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment

Pediatrics

Volumn 131, Issue 4, 2013, Pages

  Chen, Solomon Chih Cheng ^a,b   Toy, Mehlika ^a,c   Yeh, Jennifer M ^a   Wang, Jung Der ^d   Resch, Stephen ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Carrier rate; Cost effectiveness analysis; Hepatitis B; Immunoglobulin; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ANTIBODY SCREENING; ANTIGEN DETECTION; ARTICLE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; ENDEMIC DISEASE; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEPATITIS B; HEPATITIS B VACCINATION; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; INFANT; INFECTION CONTROL; INFECTION RISK; NEWBORN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TAIWAN; VACCINATION; VERTICAL TRANSMISSION; VIRUS CARRIER; VIRUS LOAD;

EID: 84875991895     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1262     Document Type: Article

References (40)

1. Custer B, Sullivan SD, Hazlet T.K., Iloeje U., Veenstra DL, Kowdley KV Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004; 38(10 suppl 3):S158-S168
2. Boyles S. Is universal better than selective immunization in developing world? Vaccines (HBV). Hepatitis Wkly. 1998:7-8
3. Krahn M, Detsky AS Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Med Decis Making. 1993; 13(1):4-20
4. Mast EE, Margolis HS, Fiore A.E., et al; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54(RR-16):1-31
5. Zhang SX, Dang RB, Zhang W.D., Liang XF, Cui FQ Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2008; 29 (10):1003-1008
6. La Torre G., Nicolotti N, de Waure C, et al An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J. 2008; 5:84
7. Tu HA, Woerdenbag HJ, Kane S, Riewpaiboon A., van Hulst M, Postma MJ Economic evaluations of hepatitis B vaccination for developing countries. Expert Rev Vaccines. 2009; 8(7):907-920
8. Romano L, Paladini S, Van Damme P, Zanetti AR The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis. 2011; 43(SUPPL. 1):S2-S7
9. Beasley RP, Hwang LY, Lee G.C., et al Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983; 2 (8359):1099-1102
10. Zanetti AR, Dentico P, Del Vecchio Blanco C, et al. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B: final report. J Med Virol. 1986; 18(4):327-334
11. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol. 2009; 19(4):231-234
12. Chen HL, Lin LH, Hu F.C., et al Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012; 142 (4):773-781, e772
13. Wong VC, Ip HM, Reesink H.W., et al Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study. Lancet. 1984; 1(8383):921-926
14. Lo KJ, Tsai YT, Lee S.D., et al Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepatogas-troenterology. 1985; 32(2):65-68
15. Chen DS, Hsu NH, Sung J.L., et al A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987; 257(19):2597-2603
16. Ni YH, Chen DS Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris). 2010; 58(4):296-300
17. Huang K, Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine. 2000; 18 (SUPPL. 1):S35-S38
18. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007; 12(3):160-167
19. Ni YH, Huang LM, Chang M.H., et al Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology. 2007; 132(4):1287-1293
20. Chang MH, You SL, Chen C.J., et al; Taiwan Hepatoma Study Group. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009; 101(19):1348-1355
21. Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009; 50(4):805-816
22. Lolekha S, Warachit B, Hirunyachote A., Bowonkiratikachorn P, West DJ, Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine. 2002; 20(31-32):3739-3743
23. Japan Infectious Disease Surveillance Center. Immunization schedule in Japan. Published April 1, 2011. Available at: http://idsc.nih.go.jp/vaccine/ dschedule/Imm11EN.pdf. Accessed February 8, 2013
24. Houweling H, Wittevrongel CF, Verweij M, Ruitenberg EJ; National Immunisation Programme Review Committee of the Health Council of the Netherlands. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate. Vaccine. 2010; 28(49):7723-7730
25. Lin HH, Kao JH, Chang T.C., Hsu HY, Chen DS Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol. 2003; 69(4):466-470
26. Liu CY, Chang NT, Chou P. Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan. Vaccine. 2007; 25(44):7706-7710
27. Wheeley SM, Jackson PT, Boxall E.H., et al Prevention of perinatal transmission of hepatitis B virus (HBV): a comparison of two prophylactic schedules. J Med Virol. 1991; 35(3):212-215
28. Sehgal A, Sehgal R, Gupta I., Bhakoo ON, Ganguly NK Use of hepatitis B vaccine alone or in combination with hepatitis B immunoglobulin for immunoprophylaxis of perinatal hepatitis B infection. J Trop Pediatr. 1992; 38(5):247-251
29. Edmunds WJ, Medley GF, Nokes D.J., O'Callaghan CJ, Whittle HC, Hall AJ Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect. 1996; 117(2): 313-325
30. Shao ZJ, Zhang L, Xu J.Q., et al Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol. 2011; 83 (5):791-795
31. Wiseman E, Fraser MA, Holden S, et al Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009; 190(9):489-492
32. Zanetti AR, Magliano EM, Tanzi E, et al HBIG immunoprophylaxis of babies born to HBsAg carrier mothers. Dev Biol Stand. 1983; 54:383-389
33. Bureau of National Health Insurance, Department of Health, Executive Yuan, Taiwan. Medical care payments of National Health Insurance in Taiwan. Published 2011. Available at: www.nhi.gov.tw/webdata/webdata. aspx?menu=20&menu-id=710&webdata-id= 3633&WD-ID=900. Accessed December 20, 2012
34. World Health Organization. Hepatitis B Surface Antigen Assays: Operational Characteristics (Phase I), Report 2. Geneva, Switzerland: World Health Organization; 2004
35. Scheiblauer H, El-Nageh M, Diaz S., et al Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010; 98(3 Pt 2):403-414
36. Ratnam S, Tobin AM Comparative evaluation of commercial enzyme immunoassay kits for detection of hepatitis B sero-markers. J Clin Microbiol. 1987; 25(2):432-433
37. Mitchell T, Armstrong GL, Hu D.J., Wasley A., Painter JA The increasing burden of imported chronic hepatitis B - United States, 1974-2008. PLoS ONE. 2011; 6(12): e27717
38. Rots NY, Wijmenga-Monsuur AJ, Luytjes W., et al Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations. Vaccine. 2010; 28(4): 893-900
39. National Statistics, Republic of China (Taiwan). Numbers and rates of births (by nationality of mothers). Published 2010. Available at: www.stat.gov.tw/ct.asp?xItem=15409&CtNode=3622&mp=4. Accessed March 16, 2012
40. Lin CC, Hsieh HS, Huang Y.J., Huang YL, Ku MK, Hung HC Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health. 2008; 8:49